Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Mar 22;14(7):557.
doi: 10.3390/nano14070557.

Current Advances of Nanomaterial-Based Oral Drug Delivery for Colorectal Cancer Treatment

Affiliations
Review

Current Advances of Nanomaterial-Based Oral Drug Delivery for Colorectal Cancer Treatment

Nuoya Wang et al. Nanomaterials (Basel). .

Abstract

Colorectal cancer (CRC) is a common malignant tumor, and traditional treatments include surgical resection and radiotherapy. However, local recurrence, distal metastasis, and intestinal obstruction are significant problems. Oral nano-formulation is a promising treatment strategy for CRC. This study introduces physiological and environmental factors, the main challenges of CRC treatment, and the need for a novel oral colon-targeted drug delivery system (OCDDS). This study reviews the research progress of controlled-release, responsive, magnetic, targeted, and other oral nano-formulations in the direction of CRC treatment, in addition to the advantages of oral colon-targeted nano-formulations and concerns about the oral delivery of related therapeutic agents to inspire related research.

Keywords: colorectal cancer; nano-drug delivery system; oral; oral colon-targeted drug delivery system (OCDDS).

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
The scheme represents physiological environmental factors and major challenges for CRC therapy.
Figure 2
Figure 2
Schematic representation of the preparation of Gd-MHAPNPs and the mechanism of drug release from different physiological environments in GIT [50]. Reprinted with permission from [50].
Figure 3
Figure 3
Schematic representation of the drug loading of MNPs and drug release upon application of external stimuli [65]. Author opens copyright and authorizes reprinting from [65].
Figure 4
Figure 4
Structure of three common anticancer drugs 5-FU, oxaliplatin, and irinotecan for treating colon cancer via MNPs [65]. Author opens copyright and authorizes reprinting from [65].
Figure 5
Figure 5
Schematic representation of CD133-targeted nanoparticle delivery mechanism [77]. Reprinted with permission from [77].

Similar articles

Cited by

References

    1. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Dekker E., Tanis P.J., Vleugels J.L.A., Kasi P.M., Wallace M.B. Colorectal cancer. Lancet. 2019;394:1467–1480. doi: 10.1016/S0140-6736(19)32319-0. - DOI - PubMed
    1. de la Rica R., Aili D., Stevens M.M. Enzyme-responsive nanoparticles for drug release and diagnostics. Adv. Drug Deliv. Rev. 2012;64:967–978. doi: 10.1016/j.addr.2012.01.002. - DOI - PubMed
    1. Kaźmierczak Z., Szostak-Paluch K., Przybyło M., Langner M., Witkiewicz W., Jędruchniewicz N., Dąbrowska K. Endocytosis in cellular uptake of drug delivery vectors: Molecular aspects in drug development. Bioorganic Med. Chem. 2020;28:115556. doi: 10.1016/j.bmc.2020.115556. - DOI - PubMed
    1. Xu B., Jiang G., Yu W., Liu D., Liu Y., Kong X., Yao J. Preparation of poly(lactic-co-glycolic acid) and chitosan composite nanocarriers via electrostatic self assembly for oral delivery of insulin. Mater. Sci. Eng. C Mater. Biol. Appl. 2017;78:420–428. doi: 10.1016/j.msec.2017.04.113. - DOI - PubMed

LinkOut - more resources